Practicability, safety, and efficacy of a “German model” for opioid conversion to oral levo-methadone

[1]  M. Tegeler,et al.  Morphine to Methadone Conversion: An Interpretation of Published Data , 2011, The American journal of hospice & palliative care.

[2]  C. Eap,et al.  Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc interval. , 2010, Archives of internal medicine.

[3]  A. Aguirre-Jaíme,et al.  Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors. , 2009, Journal of pain and symptom management.

[4]  J. Molnar,et al.  The Effects of Chiral Isolates of Methadone on the Cardiac Potassium Channel IKr , 2008, Cardiology.

[5]  J. Gaertner,et al.  Methadone: a closer look at the controversy. , 2008, Journal of pain and symptom management.

[6]  K. Bain,et al.  A systematic review of opioid conversion ratios used with methadone for the treatment of pain. , 2008, Pain medicine.

[7]  J. Gaertner,et al.  High dose levo-methadone treatment for cancer pain in a patient with a history of drug addiction. , 2008, Journal of pain and symptom management.

[8]  P. Mehler,et al.  QTc prolongation: methadone's efficacy-safety paradox , 2006, The Lancet.

[9]  S. Kaasa,et al.  Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network , 2005, Palliative medicine.

[10]  L. Radbruch,et al.  Drugs in palliative care: results from a representative survey in Germany , 2004, Palliative medicine.

[11]  K. Foley.  Opioids and chronic neuropathic pain. , 2003, The New England journal of medicine.

[12]  D. Tse,et al.  An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: an open uncontrolled prospective study in a Chinese population , 2003, Palliative medicine.

[13]  E. Bruera,et al.  Methadone use in cancer patients with pain: a review. , 2002, Journal of palliative medicine.

[14]  S. Watanabe.  Methadone: The Renaissance , 2001, Journal of palliative care.

[15]  C. Ostgathe,et al.  A German model for methadone conversion , 2001, The American journal of hospice & palliative care.

[16]  Mellar P. Davis,et al.  Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration , 2001, Supportive Care in Cancer.

[17]  J. Body,et al.  Opioid switch to oral methadone in cancer pain , 2000, Current opinion in oncology.

[18]  C. Brunelli,et al.  Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  M. Makin,et al.  The use of methadone in cancer pain poorly responsive to other opioids , 1998 .

[20]  E. Bruera,et al.  Opioid rotation in patients with cancer pain: A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine , 1996, Cancer.

[21]  E. Schultheisz.  [CARL GUSTAV CARUS]. , 1964, Orvosi hetilap.

[22]  C. Ripamonti,et al.  Strategies for the Treatment of Cancer Pain in the New Millennium , 2012, Drugs.

[23]  F. Elsner,et al.  Cancer Pain Management , 2007 .